Answers are grounded in this paper and cite their sources.
A series of 1,11-cyclic analogs of pyripyropene A were prepared. Replacement of the 1,11-acyl groups of pyripyropenes with 1,11-cyclic acetals effectively improved in vitro acyl CoA:cholesterol acyltransferase (ACAT) inhibitory activity. Especially noteworthy is benzylidene acetal analog 35, the most potent inhibitor (IC50 = 5.6 nM) among the derivatives prepared so far, which showed 16 times more potent inhibitory activity than pyripyropene A.
No takes yet. Share an insight, caveat, or question.
Obata et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: